Literature DB >> 14527282

Vaccinia virus motility.

Geoffrey L Smith1, Brendan J Murphy, Mansun Law.   

Abstract

Vaccinia virus (VV), the virus smallpox vaccine, replicates in the cytoplasm of infected cells. The intracellular movement of this large virus would be inefficient without specific transport mechanisms; therefore, VV uses microtubules for movement during both entry and egress. In addition, the dissemination of virus from infected cells to adjacent cells is promoted by the polymerization of actin beneath cell surface virions to drive virus particles away from the cell. Last, the roles of different VV particles in virus movement within and between hosts are discussed.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14527282     DOI： 10.1146/annurev.micro.57.030502.091037

Source DB:  PubMed          Journal:  Annu Rev Microbiol        ISSN： 0066-4227            Impact factor:   15.500


  43 in total

Review 1.  Discovery of antivirals against smallpox.

Authors:  Stephen C Harrison; Bruce Alberts; Ellie Ehrenfeld; Lynn Enquist; Harvey Fineberg; Steven L McKnight; Bernard Moss; Michael O'Donnell; Hidde Ploegh; Sandra L Schmid; K Peter Walter; Julie Theriot
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

2.  The product of the vaccinia virus L5R gene is a fourth membrane protein encoded by all poxviruses that is required for cell entry and cell-cell fusion.

Authors:  Alan C Townsley; Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

3.  NMR assignment of the vaccinia virus envelope protein A27L.

Authors:  Feng-I Chu; Yu Ho; Der-Lii M Tzou
Journal:  J Biomol NMR       Date:  2005-06       Impact factor: 2.835

Review 4.  Virus trafficking - learning from single-virus tracking.

Authors:  Boerries Brandenburg; Xiaowei Zhuang
Journal:  Nat Rev Microbiol       Date:  2007-03       Impact factor: 60.633

5.  Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans.

Authors:  Caroline J Breitbach; James Burke; Derek Jonker; Joe Stephenson; Andrew R Haas; Laura Q M Chow; Jorge Nieva; Tae-Ho Hwang; Anne Moon; Richard Patt; Adina Pelusio; Fabrice Le Boeuf; Joe Burns; Laura Evgin; Naomi De Silva; Sara Cvancic; Terri Robertson; Ji-Eun Je; Yeon-Sook Lee; Kelley Parato; Jean-Simon Diallo; Aaron Fenster; Manijeh Daneshmand; John C Bell; David H Kirn
Journal:  Nature       Date:  2011-08-31       Impact factor: 49.962

6.  A rationally designed A34R mutant oncolytic poxvirus: improved efficacy in peritoneal carcinomatosis.

Authors:  Pragatheeshwar Thirunavukarasu; Magesh Sathaiah; Michael C Gorry; Mark E O'Malley; Roshni Ravindranathan; Frances Austin; Steven H Thorne; Zong Sheng Guo; David L Bartlett
Journal:  Mol Ther       Date:  2013-02-26       Impact factor: 11.454

7.  The envelope G3L protein is essential for entry of vaccinia virus into host cells.

Authors:  Ruzan A Izmailyan; Cheng-Yen Huang; Shamim Mohammad; Stuart N Isaacs; Wen Chang
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

8.  Vaccinia virus protein F12 associates with intracellular enveloped virions through an interaction with A36.

Authors:  Sara C Johnston; Brian M Ward
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

9.  Enteropathogenic Escherichia coli and vaccinia virus do not require the family of WASP-interacting proteins for pathogen-induced actin assembly.

Authors:  John J Garber; Fuminao Takeshima; Inés M Antón; Michiko K Oyoshi; Anna Lyubimova; Archana Kapoor; Tomoyuki Shibata; Feng Chen; Frederick W Alt; Raif S Geha; John M Leong; Scott B Snapper
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

10.  Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence.

Authors:  Aodhnait S Fahy; Richard H Clark; Emily F Glyde; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2008-10       Impact factor: 3.891
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.